To date, the available evidence about the safety and efficacy of the anthrax vaccine is resoundingly negative. Three US government anthrax vaccine initiatives represent a reckless deviation from the precautionary principle of medical ethics and fiscal responsibility.
Introducing John Abrams, MD, author of Overdosed America.
Whose children will be sacrificed in an illegal and unethical experiment in the name of Biodefense Preparedness?
"When my brother went into the hospital with pneumonia, he quickly contracted four other infections in the intensive care unit…Michael died in the ICU." Maureen Dowd, NYT Columnist.
When is it moral for a government policy to compel parents to expose their child to risk of suffering serious, irreversible injury, or even death–so that other children would live? That overriding moral question is what public health officials and the stakeholders in the increasingly Big Business of vaccines have…
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added"
On March 22, 2010 the FDA recommended suspension in the use of GlaxoSMithKline’s Rotarix vaccine–to prevent rotavirus (diarrhea)–due to contamination with pig virus. Rotarix, one of two vaccines licensed in the U.S , has already been given to about 1 million U.S. children along with 30 million worldwide.
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions."
Columbia Journalism Review–The Complicity of the Media in Drug Marketing Wed, 27 Jul 2005 An excellent article in the Columbia Journalism Review examines pharmaceutical industry hype and the media’s role in helping that industry create false impressions about the safety and benefits of newly marketed drugs: “stories trumpeting new drugs…
To view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s infomails At FDA, Graham is still the whistle-blower Loss of Trust: Big Drug Makers See Sales Decline With Their Image War hero’s death in clinical trial follows years of FDA neglect European perspective:…
FDA Slaps Pfizer on Zoloft Ads After AHRP Files Complaint Sat, 07 May 2005 On November 4, 2004, AHRP filed a complaint with the FDA about a two page Pfizer advertisement for its SSRI antidepressant, Zoloft. The ad appeared in The New York Times Magazine in October 2004, but Pfizer…
